We have introduced Re(I) tricarbonyl complexes (ReL1 ‐ ReL6) [Re(CO)3(N^N)Cl] where N^N = extensive π conjugated imidazo‐[4,5‐f]1,10‐phenanthroline derivatives that helps in strong DNA intercalation, enhanced photophysical behavior, increase the 3π‐π* character of T1 state for PDT and high value of lipophilicity for cell membrane penetration. These complexes exhibited prominent intraligand/ligand‐centered (π ‐ π*/ 1LC) absorption bands at λ 260 ‐ 350 nm and relatively weak metal‐to‐ligand charge‐transfer (1MLCT) bands within the λ 350 ‐ 550 nm range. Among the six synthesized complexes, [(CO)3ReICl(K2‐N,N‐2‐(4‐(1‐benzyl‐1H‐tetrazol‐5‐yl)phenyl)‐1H‐imidazo[4,5‐f][1,10]phenanthroline] (ReL6) exhibited outstanding potency (IC50 ~ 6 µM, PI > 9) under yellow light irradiation compared to dark conditions. Importantly, extremely lipophilic complex ReL6 showed effective penetration through the cell membrane and localized primarily in mitochondria (Pearson’s correlation coefficient, PCC = 0.918) of MDA‐MB‐231 cells. Complex ReL6 exhibited more than 9 times higher photo‐toxicity in normoxic and hypoxic environment of tumor by inducing 1O2 generation (type II PDT), radical generation triggered by NADH oxidation (type I PDT). This complex is a promising candidate for TNBC treatment in hypoxic tumors, with efficacy comparable to photofrin and have demonstrated CO release ability under UV light irradiation.
No takes yet. Share an insight, caveat, or question.
Kar et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: